Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

November 24, 2021 A study published in The BMJ looks at time since receiving the Pfizer-BioNTech COVID-19 vaccine and risk of SARS-CoV-2 infection. Dr...

September 1, 2021 A new study of nearly 7,000 children and young people in England has shed more light on the prevalence and symptoms...

September 1, 2021 A new study of nearly 7,000 children and young people in England has shed more light on the prevalence and symptoms...

August 19, 2021 A preprint, an unpublished non-peer reviewed study, looks at the impact of Delta on viral burden and vaccine effectiveness against new...

  • The authors also tried to deal with the timing of vaccinations, but I don't think the analyses provide insights here, since the UK has shifted between 12 week and 8 week schedules, as again noted by Prof Bird. https://t.co/4lHjVsyqTu - view on twitter

  • 🔵 ~86% Pfizer protection from Delta infections Ct < 30 I very much agree with biostatistics Prof Shiela Bird that focusing on cases with Ct<30 makes sense in these types of surveillance studies. Pfizer Delta protection was 86%, AZ was 69% (Table 2). https://t.co/4lHjVsyqTu - view on twitter

August 3, 2021 A study published in The Lancet Child & Adolescent Health looks at illness duration and symptom profile in symptomatic UK school-aged...

July 28, 2021 A review, published in the Cochrane Database of Systematic Reviews, looks at the use of Ivermectin for preventing and treating COVID‐19....

July 19, 2021 A statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12...

July 18, 2021 The National Institute for Health Research (NIHR) is awarding almost £20 million to 15 research studies across Britain to improve the...

July 7, 2021 The full report of the Liverpool COVID-SMART Community Testing pilot, which aimed to improve detection and bring down cases using lateral...

May 11, 2021 It has been announced that the U.S. Food and Drug Administration (FDA) has expanded the emergency use authorization for the Pfizer-BioNTech...